The largest database of trusted experimental protocols

12 protocols using mtesr1

1

Efficient Transgene Deletion in Human iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSCs were maintained on matrigel-coated dishes in mTeSR™1 (STEMCELL Technologies, Temecula, CA, USA) or PluriSTEM™ (EMD Millipore, Vancouver, BC, Canada) medium. Human iPSC colonies were treated with alphazyme (1 ml/well in a six-well plate; PAA, Linz, Austria) for 5 to 10 minutes to obtain single cells. Then 100,000 to 200,000 cells were seeded in each well of a six-well plate having mTeSR™1 or PluriSTEM™ medium with 10 μM Rock inhibitor (Y27632; Sigma-Aldrich) to prevent the cell apoptosis. Twenty-four hours later, the medium was changed to mTeSR™1 or PluriSTEM™ containing TAT–Cre (catalogue number SCR508; EMD Millipore) with different concentrations of 0.5 μM, 1 μM and 2 μM. Cells were incubated with TAT-Cre recombinant protein for 5 hours. Cells were grown for 1 week and colonies were expanded either monoclonally or polyclonally, and then polymerase chain reaction (PCR) was performed to assess transgene deletion. Transgene-deleted clones were expanded and characterized further by immunostaining and differentiation.
+ Open protocol
+ Expand
2

Culturing IMR90.4 Stem Cells under Hypoxia

Check if the same lab product or an alternative is used in the 5 most similar protocols
The IMR90.4 cell line was obtained from WiCell (Madison, Wisconsin) and grown at UC San Diego with IRB approval. The cells were maintained in antibiotic free media on 1% (vol/vol) Matrigel-GFR (#354230; BD Biosciences) coated dishes at 37°C under hypoxic conditions (10% CO2/5% O2) in mTeSR1 (StemCell Technologies). These were passaged every 4 to 6 days with Accutase (#A6964; Sigma) for 8 to 10 min, dissociated to single, quenched in mTeSR1 plus 5 µM (-) blebbistatin (B; #B0560; Sigma), pelleted at 80 g for 5 min, and resuspended in mTeSR1 + B and plated at 5,000 cells per 35 mm dish as described earlier (15 (link), 16 (link), 21 (link)).
+ Open protocol
+ Expand
3

Maintenance of Pluripotent Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stem cells were maintained antibiotic-free on 1% (vol/vol) Matrigel (MG)-GFR™ (#354230; Corning, New York, NY, USA) extracellular matrix (ECM) coated dishes at 37 °C under hypoxic conditions (10% CO2/5%O2) in mTeSR1 (Stem Cell Technologies, Vancouver, Canada) as previously described [19 (link),20 (link),21 (link),22 (link)]. Cells were passaged every 4–6 days, with Accutase (#A6964; Sigma-Aldrich, St. Louis, MO, USA) for 8–10 min, dissociated into single cells, quenched with mTeSR1 plus 5 μM blebbistatin (B; #B0560; Sigma-Aldrich, St. Louis, MO, USA), pelleted at 80× g for 5 min, resuspended in mTeSR1+B and plated at 2000 cells per single well of a 12-well plate [23 (link)]. After 48 h, cells were fed with mTeSR1 alone. To ensure cell quality, chromosomal integrity was evaluated by copy number variation (CNV) analysis using an Infinium HumanCore-24 v1.1 BeadChip (Illumina, San Diego, CA, USA).
+ Open protocol
+ Expand
4

Maintenance of Stem Cells in Hypoxia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stem cells were maintained antibiotic-free on 1% (vol/vol) Matrigel (MG)-GFR™ (#354230; Corning) extracellular matrix (ECM) coated dishes at 37 °C under hypoxic conditions (10% CO2/5%O2) in mTeSR1 (Stem Cell Technologies) as previously described65 (link),66 (link). Cells were passaged every 4–6 days, with Accutase (#A6964; Sigma) for 10–12 min, dissociated into single cells, quenched with mTeSR1 plus 5 μM blebbistatin (B; #B0560; Sigma), pelleted at 80 × g for 5 min, resuspended in mTeSR1+B and plated at 2000 cells per single well of a 12-well plate. After 48 h, cells were fed with mTeSR1 alone.
+ Open protocol
+ Expand
5

Culturing Antibiotic-Free Stem Cells in Hypoxic Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stem cells were maintained antibiotic free on 1% (vol/vol) Matrigel-GFR (#354230; BD Biosciences) coated dishes at 37°C under hypoxic conditions (10% CO2/5%O2) in mTeSR1 (Stem Cell Technologies) (Ludwig et al., 2006 (link); Yao et al., 2006 (link); Chen et al., 2011 (link); Wahlin et al., 2017 (link)). Cells were passaged every 4–6 days, with Accutase (#A6964; Sigma) for 8–10 min, dissociated to single cells, quenched with mTeSR1 plus 5 μM (-) blebbistatin (B; #B0560; Sigma), pelleted at 80 × g for 5 min, resuspended in mTeSR1 + B and plated at 5,000 cells per 35 mm dish (Walker et al., 2010 (link)). After 48 h, cells were fed without B.
+ Open protocol
+ Expand
6

Optimal Stem Cell Aggregation for Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stem cells were routinely maintained in either mTeSR1 or Essential 8 (E8). However, for all cell aggregation experiments, cells were maintained on 1% (vol/vol) Matrigel-GFR™ (BD Biosciences) coated dishes at 37 °C under hypoxic conditions (10% CO2/5%O2) in mTeSR1 (Stem Cell Technologies) prior to reaggregation28 (link), 51 (link), 71 (link). Cells were passaged with Accutase (Sigma) for 8–10 minutes, dissociated to single cells, quenched with mTeSR1 plus 5 μM blebbistatin (B; Sigma), pelleted at 80 × g for 5 minutes, resuspended in mTeSR1 + B and plated at 5,000 cells per 35 mm well32 (link). After 48 hours, cells were fed without B. To minimize cell stress, no antibiotics were used52 (link).
+ Open protocol
+ Expand
7

Directed Differentiation of Human iPSCs to Kidney Progenitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSCs (WTC11) were maintained in mTeSR™1 (Stem Cell Technologies) in matrigel (Corning) coated six well plate (Corning) in a 370C incubator with 5% CO2. Cells were dissociated with 0.5 M EDTA (Invitrogen) in Ca++ and Mg++ free PBS (Corning) upon reaching 70–80% confluence and plated in six-well plates with mTeSR™1 containing 10 µM Rho kinase inhibitor, Y27632 (EMD Millipore). After the first 48 hours, Rho kinase inhibitor was removed, and the cells were cultured in unsupplemented mTeSR™1. For directed differentiation, we followed a previously published protocol (Morizane et al., 2015 ). In Brief, iPSCs were seeded at 1.4 × 104 cells/cm2 in a 6 well plate. At 50% of confluence, media was replaced with differentiation medium containing Advanced RPMI 1640 (Thermo Fisher Scientific), 1X GlutaMAX™ (Thermo Fisher Scientific), 10 µM CHIR99021 (Reprocell) and 5ng/ml Noggin (R&D Systems). On day 4, cells were cultured with Advanced RPMI 1640, 1X GlutaMAX™ supplemented with 10 ng/ml activin A (R&D). On day 7, cells were cultured with Advanced RPMI 1640, 1X GlutaMAX™ supplemented with 10 ng/ml FGF9 (R&D) for the next two days. On day 9 of directed differentiation, cells derived from human iPSCs represent kidney progenitor cells.
+ Open protocol
+ Expand
8

Maintenance of human iPSC and H9 hESC lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human iPSC line WTC11 (a kind gift from Bruce Conklin, Gladstone Institute of Cardiovascular Disease) was maintained in mTeSR1 (Stemcell Technologies) on Matrigel (Corning)-coated six-well plates (Corning) in a 37 °C incubator with 5% CO2. At 70–80% confluence, cells were dissociated with Accutase (Stemcell Technologies) and plated on Matrigel-coated six-well plates with mTeSR™1 containing 10 μM Rho kinase inhibitor, Y27632 (EMD Millipore). Y27632 was removed after the first 48 h and thereafter media was replaced with fresh mTeSR1 every day. Human H9 (purchased from Wicell) or H9-FP ubiquitously expressing miRFP703 fused to histone H2B (a kind gift from Dr. Andrew McMahon, University of Southern California) were maintained in StemFit (amsbio) with 100 ng/ml human FGF2 (R&D) on Geltrex (Thermo Fisher Scientific)-coated six-well plates. At 70–80% confluence, cells were dissociated with Accutase and plated on Geltrex-coated six-well plates with StemFit containing 100 ng/ml human FGF2 and 10 μM Y27632. After 48 h of culture, medium was replaced with fresh StemFit containing 50 ng/ml human FGF2. After the next 48 h, medium was replaced with fresh StemFit containing 25 ng/ml human FGF2.
+ Open protocol
+ Expand
9

Cardiac Differentiation of Human Embryonic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human embryonic stem cell (hESC)-derived cardiac differentiation was induced as previously described [9 (link)]. For cardiac lineage induction, H9 hESCs (WiCell, Madison, WI, USA) were plated onto Matrigel (Corning, New York, NY, USA)-coated 6 well plate at a density of 0.5 × 106 cells/well and cultured in mTeSR1 (STEMCELL Technologies, Vancouver, BC, Canada) supplemented with cGMP for 2–3 days. Three days before cardiomyocyte differentiation, hESCs were plated on Matrigel-coated 6 well plate at a density of 0.6 × 106 cells/well and cultured in mTeSR1 supplemented with 5 μM Y27632 (Sigma-Aldrich, St. Louis, MO, USA). The culture medium was replaced with RPMI+B27 medium (RPMI1640 with B27 supplement without insulin; Gibco, Grand Island, NY, USA) supplemented with CHIR99021 (10 μM, S1263; Selleckchem, Houston, TX, USA) for 3 days. The culture medium was subsequently replaced with RPMI+B27 supplemented with IWP2 (5 μM; Tocris, Bristol, UK), followed by culture for 5 days. On day 8, the culture medium was replaced with RPMI+B27. The medium was changed every 1–2 days. Beating cardiomyocytes were observed on days 9–10. Cardiomyocytes were chemically sorted by lactate (Wako, Richmond, VA, USA).
+ Open protocol
+ Expand
10

Live Cell Staining of Embryoid Bodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
For live cell staining, EBs were incubated with mTeSR1 plus calcein FM (Sigma-Aldrich) at 1 µM. After an incubation period for 30 min, EBs were washed twice with PBS and analyzed on an inverted fluorescence microscope.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!